Jeffrey Bartlett, based in Columbus, OH, US, is currently a CTO and CIO and Co-Founder at Rampart Bioscience, bringing experience from previous roles at CSL Behring, Calimmune, Inc. and Calimmune, Inc. Jeffrey Bartlett holds a 1984 - 1991 Ph.D. in Molecular Biology @ University of Pittsburgh School of Medicine. With a robust skill set that includes Immunology, Genetics, Molecular Biology, Life Sciences, Clinical Trials and more, Jeffrey Bartlett contributes valuable insights to the industry. Jeffrey Bartlett has 1 email and 1 mobile phone number on RocketReach.